NCT02378298: Rituximab (RTX) Therapy in Patients With Active TAO |
|
|
| Active, not recruiting | 4 | 26 | Europe | Rituximab, Mabthera, Rituxan, Zytux, L01XC02, Iv Methylprednisolone, Solumedrol, peroral methylprednisolone and Methotrexate, Prednisolone | Göteborg University, Sahlgrenska University Hospital, Sweden | Ophthalmopathy, Thyroid-Associated | 02/20 | 12/24 | | |
| Recruiting | N/A | 1275 | Europe | Iodine, Placebo | Göteborg University, Sahlgrenska University Hospital, Sweden | Thyroid Gland; Node, Pregnancy, Cognitive Developmental Delay | 06/25 | 06/32 | | |
NCT05678374: Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease |
|
|
| Recruiting | N/A | 180 | Europe | | Vastra Gotaland Region | Graves Disease, Graves Ophthalmopathy, Mental Fatigue, Autoimmune Diseases, Thyroid Diseases | 12/24 | 12/24 | | |